459 related articles for article (PubMed ID: 20015155)
21. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
Tachikawa M; Uchida Y; Terasaki T
Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
[TBL] [Abstract][Full Text] [Related]
22. Delivery of peptide and protein drugs over the blood-brain barrier.
Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
[TBL] [Abstract][Full Text] [Related]
23. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
[TBL] [Abstract][Full Text] [Related]
24. Diketopiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttles.
Teixidó M; Zurita E; Malakoutikhah M; Tarragó T; Giralt E
J Am Chem Soc; 2007 Sep; 129(38):11802-13. PubMed ID: 17764181
[TBL] [Abstract][Full Text] [Related]
25. Development of the blood-brain barrier.
Engelhardt B
Cell Tissue Res; 2003 Oct; 314(1):119-29. PubMed ID: 12955493
[TBL] [Abstract][Full Text] [Related]
26. [Development of blood-brain and blood-cerebrospinal fluid barrier (author's transl)].
Wakai S
No To Shinkei; 1981 Nov; 33(11):1077-92. PubMed ID: 7037021
[TBL] [Abstract][Full Text] [Related]
27. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
28. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
Deeken JF; Löscher W
Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
[TBL] [Abstract][Full Text] [Related]
29. Structure and function of the blood-brain barrier.
Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
[TBL] [Abstract][Full Text] [Related]
30. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound, microbubbles and the blood-brain barrier.
Meairs S; Alonso A
Prog Biophys Mol Biol; 2007; 93(1-3):354-62. PubMed ID: 16959303
[TBL] [Abstract][Full Text] [Related]
32. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system.
Broadwell RD; Sofroniew MV
Exp Neurol; 1993 Apr; 120(2):245-63. PubMed ID: 8491281
[TBL] [Abstract][Full Text] [Related]
33. Effect of transport inhibitors and additional anti-HIV drugs on the movement of lamivudine (3TC) across the guinea pig brain barriers.
Gibbs JE; Rashid T; Thomas SA
J Pharmacol Exp Ther; 2003 Sep; 306(3):1035-41. PubMed ID: 12766261
[TBL] [Abstract][Full Text] [Related]
34. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
Correale J; Villa A
Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier.
Zlokovic BV; Jovanovic S; Miao W; Samara S; Verma S; Farrell CL
Endocrinology; 2000 Apr; 141(4):1434-41. PubMed ID: 10746647
[TBL] [Abstract][Full Text] [Related]
36. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
Reichel A; Begley DJ; Abbott NJ
J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
[TBL] [Abstract][Full Text] [Related]
37. The cerebrospinal fluid and barriers - anatomic and physiologic considerations.
Tumani H; Huss A; Bachhuber F
Handb Clin Neurol; 2017; 146():21-32. PubMed ID: 29110772
[TBL] [Abstract][Full Text] [Related]
38. [Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier].
Jacob A; Declèves X; Scherrmann JM
Biol Aujourdhui; 2012; 206(3):177-83. PubMed ID: 23171840
[TBL] [Abstract][Full Text] [Related]
39. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
Engelhardt B; Sorokin L
Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
[TBL] [Abstract][Full Text] [Related]
40. Getting into the brain: approaches to enhance brain drug delivery.
Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
